Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2836 AL 2850

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial

Bradley ER, Sakai K, Fernandes-Osterhold G, Szigeti B, Ludwig C, Ostrem JL, Tanner CM, Bock MA, Llerena K, Finley PR, O'Donovan A, Zuzuarregui JRP, Busby Z, McKernan A, Penn AD, Wang ACC, Rosen RC, Woolley JD.

Neuropsychopharmacology. 2025 Jul;50(8):1200-1209. doi: 10.1038/s41386-025-02097-0. Epub 2025 Apr 9.

Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An Update

Rao S, McQuay LJ, Forns J, MacKay R, Danysh HE, Doshi D, Abler V, Anthony MS, Layton JB.

Drug Saf. 2025 Aug;48(8):893-907. doi: 10.1007/s40264-025-01543-8. Epub 2025 Apr 9.

Skin α-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis

Zhao Y, Luan M, Liu J, Wang Q, Deng J, Wang Z, Sun Y, Li K.

J Neurol. 2025 Apr 9;272(5):326. doi: 10.1007/s00415-025-12978-5.

Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?

Satyanarayanan SK, Yip TF, Han Z, Zhu H, Qin D, Lee SMY.

Front Med (Lausanne). 2025 Mar 26;12:1458281. doi: 10.3389/fmed.2025.1458281. eCollection 2025.

Studying the mechanisms of neurodegeneration: C. elegans advantages and opportunities

Torres AK, Mira RG, Pinto C, Inestrosa NC.

Front Cell Neurosci. 2025 Mar 26;19:1559151. doi: 10.3389/fncel.2025.1559151. eCollection 2025.

Biological Activity and Therapeutic Potential of Coumarin Derivatives: A Comprehensive Review

Singh S, Kaushik N, Paliwal A, Sengar MS, Paliwal D.

Curr Drug Discov Technol. 2025;22(6):e15701638374546. doi: 10.2174/0115701638374546250323152450.

Biomarkers of neurodegenerative parkinsonisms: From current clinical to future biological definitions - literature review and our experience

Brenlla C, Lazaro-Hernandez C, Fernandez M, Perez-Montesino J, de Mena L, Bargallo N, Sanchez V, Perissinotti A, Niñerola-Baizan A, Perez-Soriano A, Painous C, Cámara A, Compta Y.

Neurol Neurochir Pol. 2025;59(2):97-110. doi: 10.5603/pjnns.104070. Epub 2025 Apr 10.

Mental Health of Older Adults in the Emergency Department

Lachmann M, Forrester S.

Emerg Med Clin North Am. 2025 May;43(2):303-315. doi: 10.1016/j.emc.2024.08.010. Epub 2025 Feb 14.

Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders

De Giorgi R, Ghenciulescu A, Yotter C, Taquet M, Koychev I.

J Neurol Neurosurg Psychiatry. 2025 Aug 14;96(9):870-883. doi: 10.1136/jnnp-2024-335593.

Erasing "bad memories": reversing aberrant synaptic plasticity as therapy for neurological and psychiatric disorders

Shi Z, Wen K, Sammudin NH, LoRocco N, Zhuang X.

Mol Psychiatry. 2025 Jul;30(7):3209-3225. doi: 10.1038/s41380-025-03013-0. Epub 2025 Apr 10.

Is physical therapy recommended for people with parkinson's disease treated with subthalamic deep brain stimulation? a delphi consensus study

Guidetti M, Marceglia S, Bocci T, Duncan R, Fasano A, Foote KD, Hamani C, Krauss JK, Kühn AA, Lena F, Limousin P, Lozano AM, Maiorana NV, Modugno N, Moro E, Okun MS, Oliveri S, Santilli M, Schnitzler A, Temel Y, Timmermann L, Visser-Vandewalle V, Volkmann J, Priori A.

J Neuroeng Rehabil. 2025 Apr 10;22(1):80. doi: 10.1186/s12984-025-01616-w.

Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light

Maleeva G, Matera C, Roda S, Colleoni A, De Amici M, Gorostiza P.

Med Res Rev. 2025 Sep;45(5):1407-1422. doi: 10.1002/med.22112. Epub 2025 Apr 10.

Deep brain stimulation (DBS) in movement disorders management: exploring therapeutic efficacy, neurobiological mechanisms, and clinical implications

Hussein AFA, Imran WM, Serag I, Abbas A, Mohamed Hammad E, Pastrana-Brandes S, Al-Aish ST, Mahmoud D, Zazo Hassan AM, Ghattas AS, Megali MH, Muthana A, Hashim Almusawi AA, Chaurasia B.

Ann Med Surg (Lond). 2025 Feb 28;87(4):2163-2179. doi: 10.1097/MS9.0000000000003096. eCollection 2025 Apr.

How gut microbes affect Parkinson's disease: an editorial

Nasir R, Haseeb A, Saqlain Mustafa M, Mussarat A, Ali L, Ashir Shafique M, Abbasher Hussien Mohamed Ahmed K.

Ann Med Surg (Lond). 2025 Mar 27;87(4):1787-1789. doi: 10.1097/MS9.0000000000003098. eCollection 2025 Apr.

Effects of boxing exercise in people with Parkinson's disease: a systematic review

Wang Z, Song B, Liu C, Ma H, Bai Z, Carneiro MAS, Youssef L, Chen C, Zhang L, Wang D, Wang D.

Front Aging Neurosci. 2025 Mar 27;17:1505326. doi: 10.3389/fnagi.2025.1505326. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias